These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 28258982)
1. The sodium salt of the enantiomers of ricobendazole: Preparation, solubility and chiroptical properties. Cirilli R; Guglielmi P; Formica FR; Casulli A; Carradori S J Pharm Biomed Anal; 2017 May; 139():1-7. PubMed ID: 28258982 [TBL] [Abstract][Full Text] [Related]
2. Enantiomers of triclabendazole sulfoxide: Analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt. Ferretti R; Carradori S; Guglielmi P; Pierini M; Casulli A; Cirilli R J Pharm Biomed Anal; 2017 Jun; 140():38-44. PubMed ID: 28340473 [TBL] [Abstract][Full Text] [Related]
3. Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines. Belaz KR; Denadai M; Almeida AP; Lima RT; Vasconcelos MH; Pinto MM; Cass QB; Oliveira RV J Pharm Biomed Anal; 2012 Jul; 66():100-8. PubMed ID: 22487592 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics. Wu Z; Razzak M; Tucker IG; Medlicott NJ J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800 [TBL] [Abstract][Full Text] [Related]
5. Application of Fluorescence Emission for Characterization of Albendazole and Ricobendazole Micellar Systems: Elucidation of the Molecular Mechanism of Drug Solubilization Process. Priotti J; Leonardi D; Pico G; Lamas MC AAPS PharmSciTech; 2018 Apr; 19(3):1152-1159. PubMed ID: 29218582 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode. Hilário VC; Carrão DB; Barth T; Borges KB; Furtado NA; Pupo MT; de Oliveira AR J Pharm Biomed Anal; 2012 Mar; 61():100-7. PubMed ID: 22230802 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective drug release from ketoprofen and ricobendazole matrix tablets. Alvarez C; Torrado JJ; Cadórniga R Chirality; 1999; 11(8):611-5. PubMed ID: 10467311 [TBL] [Abstract][Full Text] [Related]
8. Comparative disposition of ricobendazole enantiomers after intravenous and subcutaneous administration of a racemic formulation to calves. Cristòfol C; Virkel G; Alvarez L; Arboix M; Lanusse CE Biopharm Drug Dispos; 2000 Nov; 21(8):303-11. PubMed ID: 11514949 [TBL] [Abstract][Full Text] [Related]
9. Effect of the water content on the retention and enantioselectivity of albendazole and fenbendazole sulfoxides using amylose-based chiral stationary phases in organic-aqueous conditions. Materazzo S; Carradori S; Ferretti R; Gallinella B; Secci D; Cirilli R J Chromatogr A; 2014 Jan; 1327():73-9. PubMed ID: 24411094 [TBL] [Abstract][Full Text] [Related]
10. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. Lopez-Garcia ML; Torrado-Duran S; Torrado-Duran J; Martínez-Fernández AR; Bolás-Fernández F Int J Parasitol; 1997 Jul; 27(7):781-5. PubMed ID: 9279580 [TBL] [Abstract][Full Text] [Related]
11. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves. Lanusse CE; Virkel GL; Sanchez SF; Alvarez LI; Lifschitz AL; Imperiale F; Monfrinotti A Res Vet Sci; 1998; 65(1):5-10. PubMed ID: 9769065 [TBL] [Abstract][Full Text] [Related]
12. Analytical and semipreparative resolution of enatiomers of albendazole sulfoxide by HPLC on amylose tris (3,5-dimethylphenylcarbamate) chiral stationary phases. Zongde Z; Xingping L; Xiaomei W; Hong Z; Yanping S; Liren C; Yongmin L J Biochem Biophys Methods; 2005 Jan; 62(1):69-79. PubMed ID: 15656945 [TBL] [Abstract][Full Text] [Related]
13. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice. Vural G; Yardimci M; Kocak M; Yasar TÖ; Kurt A; Harem IS; Carradori S; Sciamanna I; Siles-Lucas M; Fabiani M; Hemphill A; Lundström-Stadelmann B; Cirilli R; Casulli A Parasitology; 2020 Nov; 147(13):1425-1432. PubMed ID: 32729453 [TBL] [Abstract][Full Text] [Related]
15. Determination of albendazole metabolites by direct injection of bovine plasma and multidimensional achiral-chiral high performance liquid chromatography. Belaz KR; Cass QB; Oliveira RV Talanta; 2008 Jun; 76(1):146-53. PubMed ID: 18585256 [TBL] [Abstract][Full Text] [Related]
16. Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma. Wu Z; Medlicott NJ; Razzak M; Tucker IG J Pharm Biomed Anal; 2005 Sep; 39(1-2):225-32. PubMed ID: 15878252 [TBL] [Abstract][Full Text] [Related]
17. Highly sensitive LC-MS/MS-ESI method for simultaneous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study. Sharma K; Kandaswamy M; Mithra C; Meena AK; Giri S; Rajagopal S; Mullangi R Biomed Chromatogr; 2012 Feb; 26(2):247-55. PubMed ID: 21633966 [TBL] [Abstract][Full Text] [Related]
18. Stability of ricobendazole in aqueous solutions. Wu Z; Tucker IG; Razzak M; Medlicott NJ J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190 [TBL] [Abstract][Full Text] [Related]
19. Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle. Cristofol C; Virkel G; Alvarez L; Sánchez S; Arboix M; Lanusse C J Vet Pharmacol Ther; 2001 Apr; 24(2):117-24. PubMed ID: 11442786 [TBL] [Abstract][Full Text] [Related]
20. Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug. Paredes AJ; Camacho NM; Schofs L; Dib A; Zarazaga MDP; Litterio N; Allemandi DA; Sánchez Bruni S; Lanusse C; Palma SD Int J Pharm; 2020 Jul; 585():119501. PubMed ID: 32512225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]